- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
4539
JPX
Week ended 31 Jul 2026
Weekly Investor Report
Nippon Chemiphar Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
1,660 JPY
1.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.6% above the Trend Line and sits at 58.0% of its 52-week range. The latest completed week returned 1.8%, after a 7.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
49
out of 100
Latest Close
1,660 JPY
31 Jul 2026
1W Return
1.8%
latest completed week
4W Return
7.1%
short-term follow-through
12W Return
-0.4%
quarterly tape
Trend Breadth
71.2%
37 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.8%
Latest completed week; four-week move 7.1%.
Indicator stack
39/55
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.6% above the Trend Line and sits at 58.0% of its 52-week range. The latest completed week returned 1.8%, after a 7.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2012-week average 0.52
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.20Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.1% over four weeks, -0.4% over 12 weeks, and 11.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year37
Trend breadth71.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.11Latest activity-pressure read.
Pressure change91.3%Four-week change in activity pressure.
Leadership-13.50Latest relative-leadership reading.
RS change51.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.1%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher10 of 2615 weeks finished lower.
Best week+9.2%Week of 10 Jul.
Worst week-4.3%Week of 17 Jul.
Latest week+1.8%Week of 31 Jul.
Shape of recent returns
Strong gains2
Modest gains8
Flat weeks1
Modest losses14
Sharp losses1
Recent vol3.4%13-week weekly-return volatility.
Base vol2.6%52-week weekly-return volatility.
Up/down split25/23Count of positive and negative weeks in the 52-week window.
Average skew2.2% / -1.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorJP Healthcare
4-week rank- / 100
Group average0.0%
Trend breadth27.0%
Trend27.0%active weekly trend signals
MD50.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryJP Drug Manufacturers - Specialty & Generic
4-week rank4 / 31
Group average-1.3%
Trend breadth3.2%
Trend3.2%active weekly trend signals
MD22.6%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis14/100Latest 12-week confirmation: trend 3/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.20; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Enterprise value to EBITDA forward of Nippon Chemiphar Co., Ltd. – TSE:4539 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 1,660 JPY | 1.8% | 1,651 JPY | 1,525 JPY | -0.11 | -13.50 | 7.2K | Off |
| 24 Jul 2026 | 1,630 JPY | 0.6% | 1,647 JPY | 1,525 JPY | -0.41 | -15.97 | 3.1K | Off |
| 17 Jul 2026 | 1,620 JPY | -4.3% | 1,644 JPY | 1,525 JPY | -0.65 | -16.41 | 3.0K | Off |
| 10 Jul 2026 | 1,692 JPY | 9.2% | 1,639 JPY | 1,526 JPY | -0.89 | -18.91 | 9.3K | Off |
| 3 Jul 2026 | 1,550 JPY | -1.1% | 1,632 JPY | 1,526 JPY | -1.31 | -27.53 | 7.5K | Off |
| 26 Jun 2026 | 1,568 JPY | 3.2% | 1,630 JPY | 1,527 JPY | -1.44 | -26.96 | 1.9K | Off |
| 19 Jun 2026 | 1,520 JPY | -0.5% | 1,628 JPY | 1,528 JPY | -1.36 | -31.66 | 2.4K | Off |
| 12 Jun 2026 | 1,528 JPY | -1.7% | 1,627 JPY | 1,529 JPY | -1.18 | -26.61 | 800 | Off |
| 5 Jun 2026 | 1,555 JPY | -3.5% | 1,625 JPY | 1,530 JPY | -0.99 | -26.61 | 600 | Off |
| 29 May 2026 | 1,611 JPY | -1.5% | 1,623 JPY | 1,531 JPY | -0.83 | -24.34 | 10.4K | On |
| 22 May 2026 | 1,635 JPY | -3.1% | 1,623 JPY | 1,531 JPY | -0.71 | -20.23 | 12.4K | On |
| 15 May 2026 | 1,687 JPY | 1.3% | 1,620 JPY | 1,532 JPY | -0.63 | -15.75 | 5.4K | On |
| 8 May 2026 | 1,666 JPY | -0.9% | 1,615 JPY | 1,531 JPY | -0.48 | -19.01 | 1.7K | On |
| 1 May 2026 | 1,681 JPY | -0.5% | 1,611 JPY | 1,531 JPY | -0.22 | -14.54 | 10.4K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.